Benzinga | Oct 6, 2020 04:03PM EDT

Aytu BioScience Q4 EPS $(0.03), Inline, Sales $14.90M Beat $11.24M Estimate

Aytu BioScience (NASDAQ:AYTU) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 97.69 percent increase over losses of $(1.30) per share from the same period last year. The company reported quarterly sales of $14.90 million which beat the analyst consensus estimate of $11.24 million by 32.56 percent. This is a 768.30 percent increase over sales of $1.72 million the same period last year.